
Blog
Gene therapy’s comeback: how scientists are trying to make it safer – Nature
It is a pity that non integrating lentiviral vectors are

It is a pity that non integrating lentiviral vectors are

In a recent study, a team of researchers used a

With a $17 million grant, UCSF Benioff Children’s Hospital in

The FDA has granted accelerated designation to PRGN-3006 for the

Mucopolysaccharidosis I is caused by mutations in the gene for

In the process of engineering CAR T cells, if the

Many people are excluded from CAR T cell-based treatments because

CAR T-cell therapy and antibody treatments are two types of

CARCIK-CD19, an investigational therapy developed by scientists in Italy, involves